AB Science announces the identification of a plasma biomarker that indicates the activity of masitinib in treating ALS
24/02/2026 – AB Science announced the identification of a potential biomarker for assessing the activity of masitinib in pathological microglial involvement in Amyotrophic Lateral Sclerosis (ALS)